Arama

EISSN 2148-4279

EJR IS INDEXED IN WEB OF SCIENCE AND PUBMED CENTRAL

European Journal of Rheumatology

PDF

HIGHLY CITED ARTICLES

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Sawalha, Amr H.; Manzi, Susan.

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

Crayne, Courtney; Cron, Randy Q.

The emerging role of lung ultrasound in COVID-19 pneumonia

Lepri, Gemma; Orlandi, Martina; Lazzeri, Chiara; Bruni, Cosimo; Hughes, Michael; Bonizzoli, Manuela; Wang, Yukai; Peris, Adriano; Matucci-Cerinic, Marco.

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

Krutzke, Sophia; Rietschel, Christoph; Horneff, Gerd.

New perspectives in the imaging of Raynaud's phenomenon

Herrick, Ariane L.; Dinsdale, Graham; Murray, Andrea.

The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis

Rosa, Irene; Romano, Eloisa; Fioretto, Bianca Saveria; Manetti, Mirko.

Pediatric Behcet's disease - clinical aspects and current concepts

Yildiz, Mehmet; Koker, Oya; Adrovic, Amra; Sahin, Sezgin; Barut, Kenan; Kasapcopur, Ozgur.

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Miossec, Pierre.

The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia

Cai, Ken; He, Jianna; Wong, Peter K. K.; Manolios, Nicholas.

Characteristics of coexisting localized scleroderma and inflammatory arthritis

Reiff, Daniel; Crayne, Courtney B.; Mannion, Melissa L.; Cron, Randy Q.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 10 results

Ranking

Release Date Sort Sort Article Type

Mass-like lesions as a rare form of neuro-Behçet’s disease: A case report and review of the literature

Nazife Şule Yasar Bilge, Suzan Şaylısoy, Timuçin Kasifoğlu, Cengiz Korkmaz

(Eur J Rheumatol 2014; 1: 34-38) DOI: 10.5152/eurjrheum.2014.007

Abstract Full Text (PDF) Related Articles

Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?

Döndü Üsküdar Cansu, Sabri Güncan, N. Şule Yaşar Bilge, Timuçin Kaşifoğlu, Cengiz Korkmaz

(Eur J Rheumatol 2014; 1: 62-66) DOI: 10.5152/eurjrheumatol.2014.019

Abstract Full Text (PDF) Related Articles

Inflammatory myopathies: One-center experience

Metin Işık, Şule Bilgen, İsmail Doğan, Levent Kılıç

(Eur J Rheumatol 2014; 1: 96-100) DOI: 10.5152/eurjrheumatol.2014.033

Abstract Full Text (PDF) Related Articles

Mass-like lesions as a rare form of neuro-Behçet’s disease: A case report and review of the literature

Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?

Inflammatory myopathies: One-center experience

Serum lipid changes and insulin resistance in familial Mediterranean fever

The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever

Therapeutic plasma exchange for refractory SLE: A comparison of outcomes between different sub-phenotypes

Exon 2: Is it the good police in familial mediterranean fever?

Comparison of clinical features in FMF patients according to severity scores: An analysis with the ISSF scoring system

Frosted Branch Angiitis in a Patient with Familial Mediterranean Fever Diagnosis

Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review